Insider Buying: Dr. Martens (LON:DOCS) Insider Purchases 167 Shares of Stock

Key Points

• Insider Giles Wilson purchased 167 shares of Dr. Martens stock on October 13th at an average cost of GBX 89 per share, bringing total recent transactions to significant levels.
• Dr. Martens stock opened at GBX 87.75, with a one-year price range between GBX 43.02 and GBX 100.87 and a market capitalization of £847.37 million.
• Equity analysts have issued mixed ratings on Dr. Martens, with one analyst giving it a "Buy" rating while the consensus rating is currently a "Hold" at an average target price of GBX 6,000.

Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson acquired 167 shares of Dr. Martens stock in a transaction dated Monday, October 13th. The stock was purchased at an average cost of GBX 89 per share, for a total transaction of £148.63.

Giles Wilson also recently made the following trade(s):

• On Wednesday, October 8th, Giles Wilson acquired 114 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 90 per share, for a total transaction of £102.60.
• On Thursday, September 11th, Giles Wilson purchased 167 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 90 per share, for a total transaction of £150.30.
• On Monday, September 1st, Giles Wilson purchased 105,838 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 91 per share, for a total transaction of £96,312.58.
• On Monday, September 1st, Giles Wilson sold 30,000 shares of Dr. Martens stock. The stock was sold at an average price of GBX 91, for a total value of £27,300.
• On Monday, September 1st, Giles Wilson purchased 30,019 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 91 per share, for a total transaction of £27,317.29.
• On Monday, September 1st, Giles Wilson sold 105,785 shares of Dr. Martens stock. The stock was sold at an average price of GBX 90, for a total value of £95,206.50.
• On Monday, August 11th, Giles Wilson purchased 194 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 77 per share, for a total transaction of £149.38.

Dr. Martens Stock Performance

Dr. Martens stock opened at GBX 87.75 on Tuesday. The stock's 50 day moving average price is GBX 88.47 and its 200 day moving average price is GBX 73.27. Dr. Martens plc has a one year low of GBX 43.02 and a one year high of GBX 100.87. The firm has a market capitalization of £847.37 million, a PE ratio of 17,550.00, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Peel Hunt raised Dr. Martens to a "buy" rating in a research report on Monday, August 18th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of GBX 6,000.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.